BioLargo reports Q3 2022 revenue of ~$1.5M, up 111% YoY; record quarter

BIOLARGO, INC.

Revenue approximately $1.5M, 13% sequential increase from Q2 and 111% YoY gain.
Preliminary results subject to review by independent registered public accounting firm.
POOPH pet odor product expected to launch in major retailers in Q4 2022.
First PFAS removal project at large industrial site advancing through multi-phase plan.
Company says it has locked in record growth rate for full year 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.